What is the appropriate management of an obstructive sigmoid mass?

Management of Obstructive Sigmoid Mass

For patients with an obstructive sigmoid mass who are surgical candidates, self-expanding metal stent (SEMS) placement as a bridge to elective surgery is a reasonable approach, allowing for one-stage resection with improved outcomes compared to emergency surgery 1.

Initial Assessment and Decision Framework

The management hinges on three critical determinations:

1. Is the patient resectable? (surgical candidate vs. non-candidate)
2. Is there evidence of perforation, peritonitis, or bowel gangrene? (requires immediate surgery)
3. What is the patient's functional status and goals of care?

Management Algorithm for Resectable Disease

If No Peritonitis/Perforation/Gangrene Present:

SEMS as Bridge to Surgery is the preferred initial approach 1:

• Allows conversion from emergency to elective surgery
• Enables one-stage resection with primary anastomosis
• Reduces permanent stoma rates
• Permits adequate bowel preparation and patient optimization
• Timing: Perform elective surgery within 2 weeks of stent placement 2

Important caveats about stenting:

• Should only be performed in centers with experienced endoscopists 2
• Avoid if multiple luminal obstructions present 1
• Contraindicated if patient is on anti-angiogenic agents (increased perforation risk) 2
• Technical success rates are lower for extracolonic malignancies 1

If Peritonitis/Perforation/Gangrene Present:

Immediate surgical resection is mandatory 3, 4:

• Primary resection with anastomosis is preferred if patient is hemodynamically stable and tension-free anastomosis is achievable 3
• Hartmann's procedure if patient is unstable or bowel viability is questionable
• Avoid non-definitive procedures (detorsion alone, mesosigmoidopexy) due to high recurrence rates 3

Management for Non-Resectable/Palliative Patients

SEMS placement is the treatment of choice for palliation 1, 2:

• Preferred over surgical diversion (colostomy)
• Provides symptom relief with lower morbidity than surgery
• Alternative: diverting colostomy if stenting unavailable or contraindicated

Surgical options (if stenting not feasible):

• Defunctioning stoma
• Bypass surgery
• Primary resection without anastomosis

Critical Pitfalls to Avoid

1. Do not place stents in patients receiving anti-angiogenic chemotherapy - dramatically increases perforation risk 2
2. Do not attempt stenting without experienced operators - operator inexperience correlates with higher perforation rates and poor oncological outcomes 2
3. Do not delay surgery beyond 2 weeks after stent placement - optimal window is 5-14 days 2
4. Do not perform non-definitive procedures (simple detorsion, mesosigmoidopexy) in surgical candidates - recurrence rates approach 40-50% 3

Evidence Considerations

The 2021 AGA guidelines 1 represent the most recent high-quality guidance and clearly support SEMS as bridge to surgery for resectable malignant colonic obstruction. While the 2019 World Journal of Emergency Surgery review 2 notes international guidelines lack consensus, this reflects older data and varying levels of evidence. The most recent randomized trials show no difference in oncological outcomes between stenting and emergency surgery when performed by experienced operators 2.

The key distinction: SEMS converts a high-risk emergency operation into a planned elective procedure, reducing mortality from 15-50% (emergency surgery) to <1% (elective after stenting) 3, 4.